Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

E-ISSN： 1096-8652|93|2|E47-E49

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.2, 2018-02, pp. : E47-E49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Maze of Diagnosing Hemophagocytic Lymphohistiocytosis: Single-Center Experience of a Series of 6 Clinical Cases

Oncology, Vol. 92, Iss. 3, 2017-01 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

Hemophagocytic lymphohistiocytosis: Diagnosis, pathophysiology, treatment, and future perspectives

By Verbsky James Grossman William

Annals of Medicine, Vol. 38, Iss. 1, 2006-03 ,pp. : 20-31

Informa Healthcare

Access to resources Recommend Favorite

Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: A case report

By Antonodimitrakis Pantelis

Upsala Journal of Medical Sciences, Vol. 118, Iss. 1, 2013-03 ,pp. : 42-45

Informa Healthcare

Access to resources Recommend Favorite

Hemophagocytic lymphohistiocytosis secondary to Varicella zoster infection in a child with Henoch–Schönlein purpura

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : e37-e38

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis

LIVER TRANSPLANTATION, Vol. 22, Iss. 9, 2016-09 ,pp. : 1245-1253

John Wiley & Sons Inc

Access to resources Recommend Favorite